skip to content
The tumor immunoenvironment Preview this item
ClosePreview this item
Checking...

The tumor immunoenvironment

Author: Michael R Shurin; Viktor Umansky; Anatoli Malyguine, (Principal Scientist)
Publisher: Dordrecht ; New York : Springer, ©2013.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Database:WorldCat
Summary:
Analysis of multidirectional immunological responses at the tumor site allows forming a new concept of The Tumor Immunoenvironment, which is introduced and discussed in the present book with a particular focus on the role of immune cells in controlling the tumor microenvironment at different stages of cancer development. The main goal of this publication is to provide an overview of the current knowledge on the  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Michael R Shurin; Viktor Umansky; Anatoli Malyguine, (Principal Scientist)
ISBN: 9789400762176 9400762178
OCLC Number: 833137657
Description: 1 online resource.
Contents: Tumor Escape from Immune Recognition. MHC Class I Antigens and the Tumor Microenvironment / Natalia Aptsiauri ... [et al.] --
Tumor-Produced Immune Regulating Factors / Mads Hald Andersen, Jürgen C. Becker, Per thor Straten --
Roles of Signaling Pathways in Cancer Cells and Immune Cells in Generation of Immunosuppressive Tumor-Associated Microenvironments / Yutaka Kawakami ... [et al.] --
T Cell Mulfunction in the Tumor Environment / Eitan Yefenof --
Signaling of Tumor-Induced Immunosuppression of Dendritic Cells / Yong Lu, Jing Yang, Qing Yi --
Tumor Microenvironment may Shape the Function and Phenotype of NK Cells Through the Induction of Split Anergy and Generation of Regulatory NK Cells / Anahid Jewett, Han-Ching Tseng --
Immune Regulators in the Tumor Immunoenvironment. The Role of Myeloid Derived Suppressor Cells in Cancer / Jonathan M. Weiss --
Macrophage Differentiation and Activation States in the Tumor Microenvironment / Jo A. Van Ginderachter --
Dendritic Cells and Cancer: Development, Dysfunction and Therapeutic Targets / Stephanie K. Watkins, Arthur A. Hurwitz --
The Role of Tumor Associated Neutrophils in Cancer / Zvi G. Fridlender --
Mast Cell Modulation of the Tumor Microenvironment / Sharon A. Oldford, Jean S. Marshall --
Regulatory T Cells in Patients with Cancer / Theresa L. Whiteside --
Tumor-Evoked Regulatory B Cells as Important Mediators of Cancer Escape / Catalina Lee-Chang, Monica Bodogai, Arya Biragyn --
Tumor Escape and Cancer Immunotherapy. Cancer Immunotherapy: Overview in Brief / Philipp Beckhove --
Programming of MDSC: New Opportunities for Targeted Therapy / Peter Svider ... [et al.] --
Therapeutic Targeting Regulatory T Cells in Tumor / Wei Wang, Weiping Zou --
ChemoImmunoModulation: Focus on Myeloid Regulatory Cells / Michael R. Shurin, Viktor Umansky --
Combining Vaccines with Therapies that Render Tumor Cells more Susceptible to Immune Mediated Killing / Nishith Singh ... [et al.] --
Prophylactic Cancer Vaccines / Pamela L. Beatty, Olivera J. Finn --
Analyzing Immune Responses in Cancer. Approaches to Immunologic Monitoring of Clinical Trials / Lisa H. Butterfield, Lazar Vujanovic, Angela D. Pardee --
Evaluation of the Tumor Immunoenvironment in Clinical Trials / Anatoli Malyguine ... [et al.] --
Analysis of Myeloid-Derived Suppressor Cells in Patients with Cancer / Peiyuan Zhu ... [et al.] --
When Results of T cell Immune Monitoring Match/Do Not Match Clinical Outcomes of Tumor Vaccine Trials: What More Could and Should We Measure? / Paul V. Lehmann, Srividya Sundararaman. 1. Role of the immunological environment in cancer initiation, development and progression --
2. The metastatic microenvironment --
3. Tumor infiltration by immune cells: pathologic evaluation and a clinical significance --
4. Immunologic interpretation of cancer biology: impact on clinical outcome --
5. Development of antitumor cellular immunity --
6. The versatile world of inflammatory chemokines in cancer --
7. Inflammation, tumor progression, and immune suppression --
8. Pleiotropic and differential functions of IL-1 alpha and IL-1 beta shape the tumor microenvironment and affect the outcome of malignancies --
9. Impact of obesity and aging on the tumor immuno-environment --
10. MHC class I antigens and the tumor microenvironment --
11. Tumor-produced immune regulating factors --
12. Roles of signaling pathways in cancer cells and immune cells in generation of immunosupressive tumor-associated microenvironments --
13. T cell mulfunction in the tumor environment --
14. Signaling of tumor-induced immunosuppression of dendritic cells --
15. Tumor microenviroment may shape the funtion and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells --
16. The roll of myeloid derived supporessor cells in cancer --
17. Macrophage differentiation and activation states in the tumor microenvironment --
18. Dendritic cells and cancer: development, dysfunction and therapeutic targets --
19. The role of tumor associated neutrphils in cancers --
20. Mast cell modulation of the microenvironment --
21. Regulatory T cells in patients with cancer --
22. Tumor-evoked regulatory B cells as important mediators of cancer escape --
23. Cancer immunotherapy: overview in brief --
24. Programming of MDSCMDSC: new opportunities for targeted therapy --
25. Therapeutic targeting regulatory T cells in tumor --
26. ChemoImmunoModulation: focus on myeloid regulatory cells --
27. Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing --
28. Prophylactic cancer vaccines --
29. Approaches to immunologic monitoring of clinical trials --
30. Evaluation of the tumor immunoenvironment in clinical trials --
31. Analysis of myeloid-derived suppressor cells in patients with cancer --
32. When results of T cell immune monitoring match/do not match clinical outcomes of tumor vaccine trials: what more could and should we measure?
Responsibility: Michael R. Shurin, Viktor Umansky, Anatoli Malyguine, editors.
More information:

Abstract:

This book examines immune cell functioning in cancer, with a focus on both experimental animal results and human clinical trials.  Read more...

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


<http://www.worldcat.org/oclc/833137657>
library:oclcnum"833137657"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
owl:sameAs<info:oclcnum/833137657>
rdf:typeschema:Book
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
<http://viaf.org/viaf/304509435>
rdf:typeschema:Person
schema:familyName"Malyguine"
schema:givenName"Anatoli"
schema:name"Malyguine, Anatoli (Principal Scientist)"
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Analysis of multidirectional immunological responses at the tumor site allows forming a new concept of The Tumor Immunoenvironment, which is introduced and discussed in the present book with a particular focus on the role of immune cells in controlling the tumor microenvironment at different stages of cancer development. The main goal of this publication is to provide an overview of the current knowledge on the complex and unique role of the immune system, tumor-associated inflammation and tumor-mediated immunomodulation in cancer progression in a way that allows understanding the logistics of cellular and molecular interactions in the tumor lesions."@en
schema:description"1. Role of the immunological environment in cancer initiation, development and progression -- 2. The metastatic microenvironment -- 3. Tumor infiltration by immune cells: pathologic evaluation and a clinical significance -- 4. Immunologic interpretation of cancer biology: impact on clinical outcome -- 5. Development of antitumor cellular immunity -- 6. The versatile world of inflammatory chemokines in cancer -- 7. Inflammation, tumor progression, and immune suppression -- 8. Pleiotropic and differential functions of IL-1 alpha and IL-1 beta shape the tumor microenvironment and affect the outcome of malignancies -- 9. Impact of obesity and aging on the tumor immuno-environment -- 10. MHC class I antigens and the tumor microenvironment -- 11. Tumor-produced immune regulating factors -- 12. Roles of signaling pathways in cancer cells and immune cells in generation of immunosupressive tumor-associated microenvironments -- 13. T cell mulfunction in the tumor environment -- 14. Signaling of tumor-induced immunosuppression of dendritic cells -- 15. Tumor microenviroment may shape the funtion and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells -- 16. The roll of myeloid derived supporessor cells in cancer -- 17. Macrophage differentiation and activation states in the tumor microenvironment -- 18. Dendritic cells and cancer: development, dysfunction and therapeutic targets -- 19. The role of tumor associated neutrphils in cancers -- 20. Mast cell modulation of the microenvironment -- 21. Regulatory T cells in patients with cancer -- 22. Tumor-evoked regulatory B cells as important mediators of cancer escape -- 23. Cancer immunotherapy: overview in brief -- 24. Programming of MDSCMDSC: new opportunities for targeted therapy -- 25. Therapeutic targeting regulatory T cells in tumor -- 26. ChemoImmunoModulation: focus on myeloid regulatory cells -- 27. Combining vaccines with therapies that render tumor cells more susceptible to immune mediated killing -- 28. Prophylactic cancer vaccines -- 29. Approaches to immunologic monitoring of clinical trials -- 30. Evaluation of the tumor immunoenvironment in clinical trials -- 31. Analysis of myeloid-derived suppressor cells in patients with cancer -- 32. When results of T cell immune monitoring match/do not match clinical outcomes of tumor vaccine trials: what more could and should we measure?"@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/1216375612>
schema:genre"Electronic books."@en
schema:inLanguage"en"
schema:name"The tumor immunoenvironment"@en
schema:publisher
schema:url<http://dx.doi.org/10.1007/978-94-007-6217-6>
schema:url
schema:url<http://lib.myilibrary.com?id=508289>
schema:url<http://site.ebrary.com/id/10715927>
schema:url<http://public.eblib.com/EBLPublic/PublicView.do?ptiID=1106181>
schema:workExample

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.